novo boosts profit outlook on obesity drug demand
Published 1 year ago • 2.3K plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
4:09
lilly pulls ahead of novo in obesity drug race
-
4:38
novo nordisk sees obesity drug fueling record profit
-
7:03
novo nordisk raises forecasts on new obesity drug
-
0:58
the weight-loss drug market is booming. who will lead the pack? watch now! #investing #pharma
-
5:26
obesity drug supply-demand imbalance is working in novo nordisk's favor: mizuho's jared holz
-
28:26
ozempic - what’s the truth behind the hype? | dw documentary
-
24:15
the spirit of our founders: the values and mindsets that created novo nordisk a century ago
-
5:26
dr. scot gottlieb on novo nodrisk's oral diabetes drug, future of weight-loss drugs
-
24:07
the ceo behind ozempic, wegovy and europe's most valuable company
-
8:33
novo, lilly & gsk - obesity, rsv & more (may 1, 2024)
-
3:58
novo nordisk record profits with weight-loss-drug demand boost
-
1:56
novo nordisk boss on ozempic and eating disorder criticism, social media pressure
-
9:39
novo nordisk ceo on wegovy, ozempic, profit forecast, us market
-
8:27
novo owner’s ceo on obesity sales boom, catalent deal
-
1:22
obesity drug maker novo nordisk lifts outlook again | reuters
-
4:50
large pharma on diverging growth paths
-
4:32
novo nordisk raises outlook fueled by obesity drug demand | anc
-
1:59
novo nordisk, eli lilly stocks see boost on obesity drugs
-
2:28
ozempic, wegovy really good value: novo nordisk ceo
-
7:57
novo nordisk ceo talks soaring weight-loss drug demand, q1 earnings
-
0:36
novo nordisk introduces wegovy in china to tackle rising obesity epidemic
-
13:06
novo nordisk ceo on catalent, ozempic and wegovy